GlassScriptPhysician profile
Gregory R White
NPI 1649406752
$12,835.48
in general payments reported to CMS, 2019-2025
34 companies · $896 in 2025
The $896 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $602 · 2021: $805 · 2022: $1,487 · 2023: $1,692 · 2024: $6,727 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,625 · Food and Beverage: $2,301 · Travel and Lodging: $1,256 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,625.00 |
| Food and Beverage | $2,301.30 |
| Travel and Lodging | $1,255.86 |
| Education | $133.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $7,854.23 | 2020-2025 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Astrazeneca Pharmaceuticals LP | $989.18 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $587.41 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| United Therapeutics Corporation | $584.58 | 2022-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $503.89 | 2020-2024 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $432.90 | 2022-2025 | Opsumit, Uptravi |
| Ethicon INC. | $222.33 | 2022-2024 | Monarch Platform |
| Medtronic, INC. | $165.31 | 2021-2025 | Illumisite |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.46 | 2019-2022 | |
| Amgen INC. | $124.46 | 2022-2025 | Tezspire |
| Galvanize Therapeutics, INC | $118.05 | 2025 | Aliya System |
| Mylan Specialty L.P. | $106.05 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2022 | |
| Sunovion Pharmaceuticals INC. | $90.46 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $87.12 | 2024-2025 | Dupixent |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $71.07 | 2022-2024 | |
| Grifols USA, LLC | $68.39 | 2022-2024 | Prolastin-C Liquid |
| Baxter Healthcare | $65.21 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Fisher & Paykel Healthcare INC | $64.95 | 2019 | |
| Qorumpartners | $62.02 | 2022 | |
| Advanced Respiratory, INC | $56.44 | 2021 | |
| Genentech USA, INC. | $54.41 | 2019 | |
| Alnylam Pharmaceuticals INC. | $47.95 | 2023 | Onpattro |
| Philips North America LLC | $40.34 | 2019-2024 | (Ak6) Vest Therapy |
| Genzyme Corporation | $37.92 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $31.76 | 2022-2024 | Winrevair |
| Mallinckrodt Enterprises LLC | $25.24 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $23.77 | 2021 | |
| Mallinckrodt Hospital Products INC. | $23.37 | 2023 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $15.58 | 2021 | |
| Gilead Sciences, INC. | $14.58 | 2021 | |
| Electromed, INC. | $14.30 | 2023 | Smartvest |
| Abbott Laboratories | $14.28 | 2023 | I-Stat |
| Inogen, INC. | $11.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.